Transformation in Immunosuppression: Are We Ready for it?
- PMID: 29884733
- PMCID: PMC6050924
- DOI: 10.1681/ASN.2018050491
Transformation in Immunosuppression: Are We Ready for it?
Keywords: randomized controlled trials; tacrolimus; transplantation.
Comment on
-
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation.J Am Soc Nephrol. 2018 Jul;29(7):1979-1991. doi: 10.1681/ASN.2018010009. Epub 2018 May 11. J Am Soc Nephrol. 2018. PMID: 29752413 Free PMC article. Clinical Trial.
References
-
- Ekberg H, Tedesco-Silva H, Demirbas A, Vítko S, Nashan B, Gürkan A, et al. ; ELITE-Symphony Study: Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med 357: 2562–2575, 2007 - PubMed
-
- Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, et al. : Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 9: 2520–2531, 2009 - PubMed
-
- Nankivell BJ, PʼNg CH, OʼConnell PJ, Chapman JR: Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: Comparison of cyclosporine and tacrolimus eras. Transplantation 100: 1723–1731, 2016 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical